pubmed-article:11282910 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11282910 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
pubmed-article:11282910 | lifeskim:mentions | umls-concept:C0004153 | lld:lifeskim |
pubmed-article:11282910 | lifeskim:mentions | umls-concept:C0003595 | lld:lifeskim |
pubmed-article:11282910 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:11282910 | lifeskim:mentions | umls-concept:C0332287 | lld:lifeskim |
pubmed-article:11282910 | lifeskim:mentions | umls-concept:C1420304 | lld:lifeskim |
pubmed-article:11282910 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
pubmed-article:11282910 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
pubmed-article:11282910 | lifeskim:mentions | umls-concept:C0965226 | lld:lifeskim |
pubmed-article:11282910 | pubmed:issue | 13 | lld:pubmed |
pubmed-article:11282910 | pubmed:dateCreated | 2001-4-3 | lld:pubmed |
pubmed-article:11282910 | pubmed:abstractText | The present study investigated whether the ACAT inhibitor avasimibe can reduce atherogenesis independently of its cholesterol-lowering effect in ApoE*3-Leiden mice. | lld:pubmed |
pubmed-article:11282910 | pubmed:language | eng | lld:pubmed |
pubmed-article:11282910 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11282910 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11282910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11282910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11282910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11282910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11282910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11282910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11282910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11282910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11282910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11282910 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11282910 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11282910 | pubmed:month | Apr | lld:pubmed |
pubmed-article:11282910 | pubmed:issn | 1524-4539 | lld:pubmed |
pubmed-article:11282910 | pubmed:author | pubmed-author:PrincenH MHM | lld:pubmed |
pubmed-article:11282910 | pubmed:author | pubmed-author:HavekesL MLM | lld:pubmed |
pubmed-article:11282910 | pubmed:author | pubmed-author:GijbelsM JMJ | lld:pubmed |
pubmed-article:11282910 | pubmed:author | pubmed-author:JukemaJ WJW | lld:pubmed |
pubmed-article:11282910 | pubmed:author | pubmed-author:de WitE CEC | lld:pubmed |
pubmed-article:11282910 | pubmed:author | pubmed-author:van... | lld:pubmed |
pubmed-article:11282910 | pubmed:author | pubmed-author:DelsingD JDJ | lld:pubmed |
pubmed-article:11282910 | pubmed:author | pubmed-author:van Der... | lld:pubmed |
pubmed-article:11282910 | pubmed:author | pubmed-author:OffermanE HEH | lld:pubmed |
pubmed-article:11282910 | pubmed:author | pubmed-author:van Der... | lld:pubmed |
pubmed-article:11282910 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:11282910 | pubmed:day | 3 | lld:pubmed |
pubmed-article:11282910 | pubmed:volume | 103 | lld:pubmed |
pubmed-article:11282910 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11282910 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11282910 | pubmed:pagination | 1778-86 | lld:pubmed |
pubmed-article:11282910 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:meshHeading | pubmed-meshheading:11282910... | lld:pubmed |
pubmed-article:11282910 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11282910 | pubmed:articleTitle | Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice. | lld:pubmed |
pubmed-article:11282910 | pubmed:affiliation | Gaubius Laboratory, TNO-PG, Leiden, the Netherlands. | lld:pubmed |
pubmed-article:11282910 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11282910 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11282910 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11282910 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11282910 | lld:pubmed |